We provide a mechanistic and epistatic link between Ngfr activity and downstream transcriptional regulation and phenotypic outcomes including AD pathological hallmarks by using in vitro 3D human neurogenesis assay, large human AD cohorts, and cell intrinsic differential gene expression analyses. The gene discussed is NGFR; the disease is Alzheimer disease.